| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.3 | 9e-19 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-08 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.19 | 3e-08 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.19 | 8e-08 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-07 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.24 | 1e-06 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.25 | 2e-06 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |